How CBD Helps Children with Treatment-Resistant Epilepsy
How CBD Helps Children with Treatment-Resistant Epilepsy
Epilepsy, affecting millions worldwide, remains a serious neurological condition. In some children, seizures do not respond to conventional treatments, leading to a diagnosis of treatment-resistant epilepsy (TRE). Cannabidiol (CBD), a non-psychoactive compound derived from cannabis, has shown promise as an adjunct therapy for children with TRE, offering an alternative to traditional anti-seizure medications. This article explores the science behind CBD’s effects on epilepsy and how it helps children with TRE, backed by research findings and real-world evidence.
Understanding Treatment-Resistant Epilepsy (TRE)
Treatment-resistant epilepsy refers to epilepsy that fails to respond to two or more anti-seizure medications. It affects around 30% of children with epilepsy, posing significant challenges for families and healthcare providers. Without effective treatment, children with TRE may experience developmental delays, cognitive issues, and physical setbacks. CBD, with its favorable safety profile, has emerged as a promising alternative to conventional anti-seizure drugs, especially for children who experience side effects or fail to respond to multiple treatments.
The Science Behind CBD and Epilepsy
CBD is one of over 100 cannabinoids found in cannabis, and unlike THC, it does not produce a “high.” Instead, it interacts with the body’s endocannabinoid system (ECS), which regulates processes like mood, appetite, immune response, and neuronal activity. Research suggests that CBD may help reduce seizures by:
Regulating neurotransmitter release: CBD may inhibit the release of glutamate, an excitatory neurotransmitter that contributes to seizure activity.
Anti-inflammatory properties: Inflammation plays a role in seizure development, and CBD’s anti-inflammatory effects may help control seizures.
Neuroprotective effects: CBD’s ability to protect brain cells and modulate neuronal signaling could be critical in its anti-seizure properties.
Key Research Supporting CBD's Efficacy for TRE
1. Epidiolex Approval by the FDA
In 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex, a purified CBD oil, for the treatment of two severe forms of epilepsy in children: Dravet syndrome and Lennox-Gastaut syndrome (LGS). Clinical trials demonstrated that Epidiolex reduced seizures significantly in these populations. For children with Dravet syndrome, seizure frequency was reduced by 39%, and for those with LGS, a 44% reduction in drop seizures was observed.
2. Open-Label Studies and Real-World Evidence
Open-label studies have shown promising results. One such study, involving 214 participants aged 1-30 years, found that CBD treatment led to a median reduction of 36.5% in seizure frequency over a 12-week period. A 2023 retrospective study further confirmed that CBD reduced seizure frequency by 50% in children with TRE, many of whom had already failed traditional anti-seizure medications.
3. Parental Reports and Quality of Life Improvements
Parents of children with TRE often report not only fewer seizures but also enhanced cognitive function, sleep, and overall behavior. These real-world reports are supported by clinical findings showing improvements in both seizure control and quality of life, making CBD a valuable adjunct therapy.
How to Access CBD for TRE
For children with TRE, CBD can be accessed in several ways:
Prescription-Based Access: Epidiolex is available by prescription for severe forms of epilepsy, like Dravet syndrome and LGS.
Medical Cannabis Programs: In states where medical cannabis is legal, CBD oil can be obtained with a medical recommendation.
Over-the-Counter (OTC) Options: High-quality CBD products are available OTC in some regions, but parents should ensure products are third-party tested for purity and accurate labeling.
Safety and Side Effects of CBD for Children
While CBD is generally well-tolerated, potential side effects may include:
Drowsiness
Decreased appetite
Diarrhea
Fatigue
In rare cases, CBD may cause liver enzyme elevation, requiring regular monitoring. It is crucial to consult with a healthcare provider to ensure safe and effective use.
Pain Solve by Jane The Rebel: A Complementary Natural Pain Relief Option
For those looking for additional relief from the discomfort associated with chronic conditions, Pain Solve by Jane The Rebel offers a natural, plant-based topical pain relief cream. With ingredients like CBD, menthol, lavender, and arnica, it can provide soothing relief to those managing pain or inflammation. Learn more about Pain Solve and how it may complement other treatments here: Pain Solve by Jane The Rebel.
Future Research and the Path Forward
Ongoing research into CBD’s potential for treating TRE and other neurodevelopmental conditions continues to expand. Studies are exploring how combining CBD with other cannabinoids, such as THC or cannabigerol (CBG), could enhance therapeutic outcomes while minimizing side effects. Further clinical trials will help refine dosing recommendations and provide more comprehensive data on the long-term effects of CBD for children with epilepsy.
Conclusion
CBD offers hope for children suffering from treatment-resistant epilepsy, providing a natural alternative when traditional medications fail. With FDA-approved Epidiolex and growing real-world evidence, CBD is gaining traction as a viable treatment option. Parents and caregivers should work closely with healthcare providers to explore the safe and effective integration of CBD into their child’s epilepsy treatment plan.
References
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
